| Name | Title | Contact Details |
|---|
Singapore General Hospital (SGH) is Singapore’s flagship hospital, providing specialist care, medical training, and conducting research to bring better care for patients. SGH is a not-for-profit institution with a long tradition of providing affordable...
Founded nearly 50 years ago and employing over 2,500 clinical, regulatory, and operational pharmacy professionals, Comprehensive Pharmacy Services is the nation`s oldest and largest provider of pharmacy support services to more than 700 hospitals and healthcare facilities across the United States and Puerto Rico. CPS helps hospital pharmacists tackle complex problems such as medication reconciliation, hyper-inflated drug costs, standardization, centralized distribution, regulatory & compliance, and 340B programs leading to increased quality, reduced admissions and lower costs. Services provided by CPS include pharmacy management, pharmacy consulting, specialized pharmacy services, telepharmacy, 340B program compliance assurance, ambulatory & retail pharmacy services, medication related transition of care, and pharmacy analytics.
KCAS Bioanalytical Labs is a Shawnee, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.
Discovery Institute of Medical Education is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.